Northern Trust Corp Codex Dna, Inc. Transaction History

Northern Trust Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$1.8 - $6.45 $99,828 - $357,717	-55,460 Reduced 77.68%	15,937 $29,000
Q1 2022 May 13, 2022	BUY	$4.12 - $10.36 $18,033 - $45,345	4,377 Added 6.53%	71,397 $383,000
Q4 2021 Feb 08, 2022	BUY	$6.31 - $11.96 $29,316 - $55,566	4,646 Added 7.45%	67,020 $723,000
Q3 2021 Nov 15, 2021	BUY	$10.15 - $19.88 $633,096 - $1.24 Million	62,374 New	62,374 $694,000

307

Ticker DNAY
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 29,518,200
Market Cap $54.6M
Description
Codex DNA, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. Its solutions include BioXp system that empowers researchers to go from a digital DNA sequence to endpoint-ready synthetic DNA...

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

Stay updated on Northern Trust Corp with notifications on news.